Eversept Partners, LP Guardant Health, Inc. Transaction History

Eversept Partners, LP

$1.26 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$16.07 - $31.84 $5.63 Million - $11.2 Million	-350,209 Reduced 77.9%	99,377 $2.87 Million
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $7.7 Million - $12.1 Million	449,586 New	449,586 $9.27 Million
Q1 2023 Nov 08, 2023	BUY	$22.92 - $33.76 $7.72 Million - $11.4 Million	336,969 Added 230.6%	483,098 $11.3 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $7.72 Million - $11.4 Million	336,969 Added 230.6%	483,098 $11.3 Million
Q4 2022 Nov 08, 2023	SELL	$25.44 - $59.78 $644,954 - $1.52 Million	-25,352 Reduced 14.78%	146,129 $3.97 Million
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $644,954 - $1.52 Million	-25,352 Reduced 14.78%	146,129 $3.97 Million
Q3 2022 Nov 08, 2023	SELL	$43.66 - $61.0 $10.3 Million - $14.3 Million	-234,894 Reduced 57.8%	171,481 $9.23 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $10.3 Million - $14.3 Million	-234,894 Reduced 57.8%	171,481 $9.23 Million
Q2 2022 Nov 08, 2023	BUY	$28.82 - $77.35 $5.57 Million - $14.9 Million	193,172 Added 90.6%	406,375 $16.4 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $5.57 Million - $14.9 Million	193,172 Added 90.6%	406,375 $16.4 Million
Q1 2022 Nov 08, 2023	BUY	$48.25 - $100.49 $10.3 Million - $21.4 Million	213,203 New	213,203 $14.1 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $5.45 Million - $11.3 Million	112,869 Added 112.49%	213,203 $14.1 Million
Q4 2021 Nov 08, 2023	SELL	$88.71 - $120.43 $2,395 - $3,251	-27 Reduced 0.03%	100,334 $10 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $2,395 - $3,251	-27 Reduced 0.03%	100,334 $10 Million
Q3 2021 Nov 08, 2023	BUY	$98.77 - $132.17 $9.73 Million - $13 Million	98,552 Added 5447.87%	100,361 $12.5 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $9.73 Million - $13 Million	98,552 Added 5447.87%	100,361 $12.5 Million
Q2 2021 Nov 08, 2023	SELL	$109.77 - $165.68 $4.22 Million - $6.37 Million	-38,438 Reduced 95.51%	1,809 $224,000
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $4.22 Million - $6.37 Million	-38,438 Reduced 95.51%	1,809 $225,000
Q1 2021 Nov 08, 2023	BUY	$127.04 - $179.1 $5.11 Million - $7.21 Million	40,247 New	40,247 $6.14 Million
Q1 2021 May 13, 2021	BUY	$127.04 - $179.1 $5.11 Million - $7.21 Million	40,247 New	40,247 $6.14 Million
Q1 2020 May 13, 2020	SELL	$59.04 - $88.81 $3.82 Million - $5.75 Million	-64,720 Closed	0 $0
Q4 2019 Nov 08, 2023	BUY	$59.49 - $82.78 $3.85 Million - $5.36 Million	64,720 New	64,720 $5.06 Million
Q4 2019 Feb 13, 2020	BUY	$59.49 - $82.78 $3.85 Million - $5.36 Million	64,720 New	64,720 $5.06 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$382 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.2M
Shares

$367 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.1M
Shares

$331 Million
0.04% of portfolio
Cadian Capital Management, LP New York, NY

6.93M
Shares

$226 Million
8.13% of portfolio
Deep Track Capital, LP Greenwich, CT

6M
Shares

$196 Million
5.07% of portfolio

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account